JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.07B |
| 2 |
Boston Scientific
BSX
|
+$657M |
| 3 |
Chevron
CVX
|
+$589M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$588M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$525M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$683M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$489M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$410M |
| 4 |
Tenaris
TS
|
+$408M |
| 5 |
JPMorgan Chase
JPM
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.59% |
| 2 | Financials | 12.79% |
| 3 | Healthcare | 10.83% |
| 4 | Technology | 10.62% |
| 5 | Energy | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NTLS
1701
DELISTED
NTELOS HLDGS CORP COM
NTLS
| $9.23M | ﹤0.01% |
740,751
+729,987
| +6,782% | +$9.48M |
2013 Q2
4 quarters
|
|
1702
Equity Lifestyle Properties
ELS
$11.2B
| $9.23M | ﹤0.01% |
417,982
+175,826
| +73% | +$3.75M |
2013 Q2
4 quarters
|
|
1703
Community Bank
CBU
$3.15B
| $9.21M | ﹤0.01% |
254,553
-46,969
| -16% | -$1.73M |
2013 Q2
4 quarters
|
|
|
LITS
1704
Lite Strategy Inc
LITS
$42M
| $9.17M | ﹤0.01% |
72,312
+12,265
| +20% | +$1.8M |
2013 Q4
2 quarters
|
|
|
SUSS
1705
DELISTED
SUSSER HOLDINGS CORPORATION COMMON STOCK
SUSS
| $9.15M | ﹤0.01% |
113,397
+85,355
| +304% | +$6.32M |
2013 Q2
4 quarters
|
|
1706
Strategic Education
STRA
$1.75B
| $9.12M | ﹤0.01% |
173,592
-14,403
| -8% | -$729K |
2013 Q2
4 quarters
|
|
1707
Thomson Reuters
TRI
$43B
| $9.09M | ﹤0.01% |
215,508
+83,004
| +63% | +$3.4M |
2013 Q2
4 quarters
|
|
1708
iShares MSCI China ETF
MCHI
$6B
| $9.08M | ﹤0.01% |
195,853
-6,922
| -3% | -$315K |
2013 Q2
4 quarters
|
|
1709
Ionis Pharmaceuticals
IONS
$7.31B
| $9.07M | ﹤0.01% |
263,317
-93,232
| -26% | -$2.94M |
2013 Q2
4 quarters
|
|
|
JPMV
1710
DELISTED
iShares Edge MSCI Min Vol Japan ETF
JPMV
| $9.06M | ﹤0.01% |
+173,000
| New | +$8.91M |
2014 Q2
0 quarters
|
|
1711
Cooper Companies
COO
$10.9B
| $9.04M | ﹤0.01% |
266,784
-695,804
| -72% | -$23M |
2013 Q2
4 quarters
|
|
1712
Flowers Foods
FLO
$1.18B
| $8.98M | ﹤0.01% |
425,957
+209,989
| +97% | +$4.34M |
2013 Q2
4 quarters
|
|
|
ESL
1713
DELISTED
Esterline Technologies
ESL
| $8.98M | ﹤0.01% |
77,974
-56,362
| -42% | -$6.22M |
2013 Q2
4 quarters
|
|
|
MLPI
1714
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
| $8.91M | ﹤0.01% |
199,967
-1,680
| -0.8% | -$70.2K |
2013 Q2
4 quarters
|
|
|
AMSG
1715
DELISTED
Amsurg Corp
AMSG
| $8.91M | ﹤0.01% |
195,533
+10,787
| +6% | +$495K |
2013 Q2
4 quarters
|
|
1716
Ultragenyx Pharmaceutical
RARE
$1.45B
| $8.89M | ﹤0.01% |
198,075
+16,515
| +9% | +$680K |
2014 Q1
1 quarter
|
|
|
CVG
1717
DELISTED
Convergys
CVG
| $8.88M | ﹤0.01% |
414,450
+86,119
| +26% | +$1.87M |
2013 Q2
4 quarters
|
|
|
ARGO
1718
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $8.85M | ﹤0.01% |
240,816
-7,236
| -3% | -$246K |
2013 Q2
4 quarters
|
|
|
KG
1719
Kestrel Group
KG
$38.9M
| $8.81M | ﹤0.01% |
36,452
+13,944
| +62% | +$3.4M |
2013 Q2
4 quarters
|
|
1720
Mueller Water Products
MWA
$3.36B
| $8.81M | ﹤0.01% |
1,020,302
+138,787
| +16% | +$1.23M |
2013 Q2
4 quarters
|
|
1721
Omega Healthcare
OHI
$13.7B
| $8.8M | ﹤0.01% |
238,757
-363,529
| -60% | -$13M |
2013 Q2
4 quarters
|
|
1722
Tanger
SKT
$3.96B
| $8.79M | ﹤0.01% |
251,287
+97,523
| +63% | +$3.47M |
2013 Q2
4 quarters
|
|
|
SRNE
1723
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $8.76M | ﹤0.01% |
1,297,847
-7,318
| -0.6% | -$55.2K |
2013 Q4
2 quarters
|
|
|
AMTG
1724
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $8.75M | ﹤0.01% |
523,329
-25,642
| -5% | -$421K |
2013 Q2
4 quarters
|
|
1725
Simmons First National
SFNC
$3.28B
| $8.75M | ﹤0.01% |
444,184
+7,082
| +2% | +$138K |
2013 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2014 Portfolio in Review
As of Q2 2014, JP Morgan Chase held 3,788 positions worth $394B, up 8.7% from $362B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase deployed $14.1B of net new capital in Q2 2014, opening 280 new positions and adding to 1,498 existing holdings. Its largest new stake was Ally Financial: 13,696,118 shares worth $327M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Twitter, Inc., an estimated $489M trimmed.
- JP Morgan Chase's largest Q2 2014 buy was Ally Financial: 13,696,118 shares worth $327M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $1.07B increase.
- JP Morgan Chase's biggest Q2 2014 reduction was Twitter, Inc., cutting an estimated $489M.
- JP Morgan Chase fully exited GE Aerospace in Q2 2014, selling an estimated $683M.
- JP Morgan Chase's ten largest holdings make up 17% of its $394B portfolio in Q2 2014.
- JP Morgan Chase opened 280 new positions and closed 300 in Q2 2014.
- JP Morgan Chase's portfolio value rose 8.7% quarter-over-quarter to $394B.
Based on JP Morgan Chase's 13F filing for Q2 2014, filed 14 Aug 2014.